» Articles » PMID: 9264009

Insulin Resistance in Adult Polycystic Kidney Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1997 Aug 1
PMID 9264009
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Adult polycystic kidney disease (APKD) is a common hereditary disease with renal and extra-renal manifestations. There are at least three genes responsible for this disease. The polycystic kidney disease 1 (PKD1) gene product is a membrane protein involved in cell-cell and cell-matrix interactions and has a widespread tissue distribution. Abnormal membrane fluidity in erythrocytes from APKD patients is due to altered membrane proteins. Membrane fluidity of mononuclear cells is related to whole body insulin sensitivity. Insulin sensitivity might therefore be disturbed in APKD if the erythrocyte membrane abnormality is also present in other cells. Therefore, we investigated insulin sensitivity in 15 APKD patients and 20 normal subjects matched for age and sex. Insulin sensitivity was assessed by a short insulin tolerance test to derive the first-order rate constant for the disappearance of glucose (Kitt) and mononuclear leukocyte membrane fluidity was measured by fluorescence anisotropy. The Kitt value (% mmol.liter-1.min-1) was lower in APKD patients than in normal subjects [median (range) 2.2 (1.5 to 6.3) vs. 4.1 (2.0 to 5.4). P < 0.001]. Fasting plasma insulin concentrations were negatively correlated with the Kitt values (r = -0.66, P < 0.001). Core region anisotropy was significantly lower (higher fluidity) in leukocytes from APKD patients [mean (SEM) 0.164 (0.003) vs. 0.174 (0.001), P < 0.001]. Insulin sensitivity was positively correlated with the fluorescence anisotropy of the core region of leukocyte membranes (r = 0.81, P = 0.0001). In conclusion, APKD patients were insulin resistant and some patients were hyperinsulinemic, which may indicate increased cardiovascular risk. The cellular basis of the insulin resistance may be directly related to the proteins causing the disease or to the general change in membrane properties.

Citing Articles

Clinical characteristics and outcomes of kidney transplantation in autosomal dominant polycystic kidney disease patients.

Lee J, Myung J, Gang S, Ryu H, Yi N, Yang J J Nephrol. 2024; .

PMID: 39495478 DOI: 10.1007/s40620-024-02101-8.


Predictors of autosomal dominant polycystic kidney disease progression: a Brazilian single-center cohort.

Nishimoto I, Santos A, Bianchini J, Santos L, Martini M, Silva V J Bras Nefrol. 2024; 46(3):e20230040.

PMID: 38935976 PMC: 11210993. DOI: 10.1590/2175-8239-JBN-2023-0040en.


Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.

Korsmo H, Ekperikpe U, Daehn I Antioxidants (Basel). 2024; 13(6).

PMID: 38929151 PMC: 11200862. DOI: 10.3390/antiox13060712.


Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.

Bjornstad P, Richard G, Choi Y, Nowak K, Steele C, Chonchol M Am J Kidney Dis. 2024; 84(3):286-297.e1.

PMID: 38621633 PMC: 11344681. DOI: 10.1053/j.ajkd.2024.02.016.


Is autosomal dominant polycystic kidney disease an early sweet disease?.

Dachy A, Decuypere J, Vennekens R, Jouret F, Mekahli D Pediatr Nephrol. 2022; 37(9):1945-1955.

PMID: 34988697 DOI: 10.1007/s00467-021-05406-z.